Access 'Our View' Join Forsyth Barr to access 'Our View' for this stock and many others. The Company posted accelerating revenue growth in key growth markets as it benefitted from major commercial milestones attained during H1 of the financial year. Pacific Edge in top 50 Dunedin cancer diagnostic company Pacific Edge has edged high street clothing retailer Hallenstein Glasson out of the stock exchange's NZX top 50 index. This will be a virtual meeting. [read more], Speeches by our Chairman and CEO along with the presentation for today's meeting. In this video, we will take you through our full analysis on Pacific Edge (PEB). 2019 « Previous Next » Apr 18th, 2019 Director Appointment. They specialise … [read more]. Forums. Stock analysis for Pacific Edge Ltd (PEB:NZX) including stock price, stock chart, company news, key statistics, fundamentals and company profile. It operates in the Commercial and Research segments. Shares in Pacific Edge rallied after the cancer diagnostics company said it would be included in the S&P/NZX 50 Indices from October 21. [read more], Video footage of the Pacific Edge 2020 Annual Shareholder Meeting is now available to watch online. Pacific Edge Limited [NZX: PEB] is experiencing a trading windfall today, jumping from 27c to 54c. More Details. Pacific Edge — established in 2001 — is a cancer-diagnostics company founded in Dunedin. Activity (daily) [read more] Oct 14th, 2020 Pacific Edge Joins Top NZ Companies on S&P/ NZX 50 Index Cancer diagnostics company, Pacific Edge Limited, (NZX: PEB) is pleased to announce the appointment of John Duncan to the Board as an Independent Director; effective from 30 April 2019. So it's clear an insider wanted to buy, even at a higher price than the current share price (being NZ$0.11). Radius Residential Care Limited (NZX:RAD) Focussed on providing health and aged care facilities to the elderly this Company works through more than 22 branches across New Zealand. Biotech company Pacific Edge, which has been granted a US patent for skin cancer detection, has helped nudge the NZX 50 Index slightly higher. Pacific Edge — established in 2001 — is a cancer-diagnostics company founded in Dunedin. Share Market Tools for Successful Investing. Pacific Edge is listed on the NZX Main Board and provides an opportunity to invest into the fast growing cancer diagnostic market. We provide high quality … Post author By Lewis Hurst; ... maybe they just get 50%, which would be a lot! Join the HotCopper ASX share market forum today for free. Pacific Edge gives NZX 50 a nudge up ON a day of mixed tradiing on the New Zealand market, the share price of biotech company Pacific Edge … Index inclusion will increase our relevance to New Zealand and offshore investors and there are a number of funds that are mandated to hold stock of those companies that are in the NZX50. HotCopper has news, discussion, prices and market data on Pacific Edge Limited. Pacific Edge Ltd. Since June 2020, the stock has risen 450%! Hallenstein Glasson Holdings Limited (HLG) will be removed from the NZX 50 Index, as the lowest ranked constituent. We welcome press and media enquiries. Pacific Edge Limited [NZX:PEB] has enjoyed a dream run in trading today, emerging as the star performer on the New Zealand Stock Exchange. The benchmark NZX 50 advanced 0.5 per cent, or 63.573 points, to close at 12,742.59 on Tuesday. [read more], Transformational reimbursement milestone for Pacific Edge with the notification of LCD coverage for CMS patients in the USA. The company has offices in Hershey, Pennsylvania, and its head office in Dunedin, New Zealand.Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. This resource allows you to click through to a simple Profile of each company, offering basic details of their operations, earnings and capital structure. The Commercial segment involves the sales, marketing, laboratory, and support to … It operates in two segments, Commercial and Research. Here is a list of the NZX50 companies as at Friday, March 26, 2021, ranked by capitalisation. Pacific Edge's share price is $1.47, giving it market capitalisation of $468 million, while Hallenstein's is $3.08, … Read More. [read more], Pacific Edge’s Annual Report for the year ended 31 March 2020 is now available for review. ), you could argue that target ROI should be a dividend of 10% of initial investment, at least! This would at best be a multiple of 10 instead of the multiple of 25 that I used. The top three performing tech stocks increased in price by an average of 359%. HotCopper has news, discussion, prices and market data on Pacific Edge Limited. For further assistance, please feel free to contact us. Pacific Edge is strengthening and expanding its executive team as the company positions itself for growth following the recent commercial milestones in the multi-billion dollar US healthcare market. The Company’s expertise lies in cancer genetics, bioinformatics, molecular oncology, technology … Calendario; Paesi; Indicatori; Mercati. They specialise in genetic-biomarker testing known as CxBladder. We provide high quality market information, featuring real time stock quotes, market data, market news and tools to … ... church technology service PushPay and cancer diagnostic firm Pacific Edge. The Commercial segment involves the sales, marketing, laboratory, and support to run the commercial businesses worldwide. It operates in the Commercial and Research segments. A comprehensive list of companies available on stock exchanges that can be browsed alphabetically, by sector, or by country. The LCD coverage facilitates reimbursement for CMS patients using Cxbladder Detect and Cxbladder Monitor. In the last twelve months, the biggest single purchase by an insider was when insider John Duncan bought NZ$125k worth of shares at a price of NZ$0.15 per share. PEB.NZX performance. Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) have signed an agreement with Hawke’s Bay District Health Board (HBDHB), further extending the adoption and commercial coverage of Cxbladder for the New Zealand population Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. The S&P Dow Jones Indices announcement can be read here. Rewards. Pacific Edge Limited is pleased to report accelerating revenue growth in key growth markets, as it starts to benefit from the major commercial milestones achieved during the first half of the financial year ... Pacific Edge Limited (NZX: PEG) Unaudited Financial Results to 30 Sept 2020. S&P Dow Jones Indices have confirmed that Pacific Edge will be added to the NZX 50, NZX 50 Portfolio, and NZX MidCap Indices, effective prior to the opening of trading on 21 October 2020. Stock analysis for Pacific Edge Ltd (PEB:NZX) including stock price, stock chart, company news, key statistics, fundamentals and company profile. On 17 February, Pacific Edge last traded flat at $1.000. Why I Sold My PEB Shares. Changes to Pacific Edge’s executive suite as company grows. Specialists in the discovery of diagnostic and prognostic tests for the better detection and management of cancer. [read more], We're pleased to announce the release of our audited financial results for the 12 months ended 31 March 2020 (FY20). We provide high quality market information, featuring real time stock quotes, market data, market news and tools to … Since June 2020, the stock has risen 450%! It's been a transformational half year for the company with commercial agreements and accelerating revenue growth. Tag: Pacific Edge Ltd (NZX:PEB) Categories. Created with Sketch. Success in the US as Cxbladder testing covered by Medicare (press release) Contact Energy (NZX: CEN) Speculation Contact Energy may enter the MSCI New Zealand Index NZX operates New Zealand capital, risk and commodity markets. They specialise in genetic-biomarker testing known as CxBladder. In this video, we will take you through our full analysis on Pacific Edge (PEB). Led lower by biotech firm Pacific Edge and software developer Xero, the NZX 50 Index fell 24.058 points, or 0.5 per cent, to 5091.431 on Friday. See the latest news and presentations, keep up to date with our newsletters and shareholder reports, find out when we are holding shareholder meetings and check up … Pacific Edge — established in 2001 — is a cancer-diagnostics company founded in Dunedin, New Zealand. This would at best be a multiple of 10 instead of the multiple of 25 that I used. It operates in two segments, Commercial and Research. ASX Announcements and Latest News from Pacific Edge Limited. Peer reviewed publication of further independent, real-world clinical evidence highlights the effectiveness, safety and long term clinical utility from inclusion of Cxbladder in a new standard of care in mainstream clinical use. Pacific Edge is strengthening and expanding its executive team as the company positions itself for growth following the recent commercial milestones in the multi-billion dollar US healthcare market. ), you could argue that target ROI should be a dividend of 10% of initial investment, at least! [read more], An important personnel update for shareholders and investors. By Suze Metherell March 13 (BusinessDesk) – Pacific Edge, the bladder cancer test developer whose shares have soared in the past year, will join the NZX 50 Index this month, replacing retailer Hallenstein Glasson Holdings, whose stock has tumbled in the same period. 2020 « Previous Next » Jul 3rd, 2020 Pacific Edge Notified of Positive LCD Decision in USA. $0.000. Pacific Edge Ltd | 973 followers on LinkedIn. Pacific Edge Limited () Stock Market info Recommendations: Buy or sell Pacific Edge stock? While browsing the list of companies that experienced the highest price change in the past 52 weeks, it showcases the attractiveness of tech stocks on the NZX. Terms & Conditions | Privacy Policy | © Pacific Edge 2021 | Website by Myth | Last Updated: 13 Oct 2020 11:40 pm. Pacific Edge Limited’s (): Pacific Edge Limited, a cancer diagnostics company, develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers.On 31 March 2018, the NZ$104.92M market-cap posted a loss of -NZ$19.64M for its most recent financial year. NZX operates New Zealand capital, risk and commodity markets. Why I Sold My PEB Shares. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a midkine (urine) based suite of bladder cancer diagnostic tools. ON a day of mixed tradiing on the New Zealand market, the share price of biotech company Pacific Edge has jumped nearly 10 per cent. Pacific Edge Limited. They specialise … This is rewarding for our long standing and loyal shareholders who have supported our company as we have worked towards achieving our goals.”S&P Dow Jones Indices have confirmed that Pacific Edge will be added to the NZX 50, NZX 50 Portfolio, and NZX MidCap Indices, effective prior to the opening of trading on 21 October 2020.The S&P Dow Jones Indices announcement can be read here. NZX:PEB. The Company’s expertise lies in cancer genetics, bioinformatics, molecular oncology, technology … Join us Sign in. NZX 50 Components Real-time streaming quotes of the NZX 50 index components. [read more], New Zealand Public Health Providers Counties Manukau Health and MidCentral DHB (who combine to serve a population of approximately 805,000) are now dispatching Cxbladder test sample systems to patients at home. Pacific Edge Insider Transactions Over The Last Year . Post author By Lewis Hurst; ... maybe they just get 50%, which would be a lot! Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 … NZX-Listed Stocks Under Sentiment Splash [read more], Pacific Edge will continue to provide essential cancer diagnostic services during the COVID-19 shutdown in both New Zealand and USA. Pacific Edge Limited develops technology for the detection and management of bladder cancer. Investing. Pacific Edge Diagnostics Notified of CMS LCD Coverage for Cxbladder® Milestone achievement for Pacific Edge Diagnostics facilitates reimbursement for Cxbladder® testing for Medicare patients.DUNEDIN, New Zealand, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Bladder cancer diagnostics provider, Pacific Edge Diagnostics, has been notified by Novitas1 that the LCD: Biomarkers for … Here you will find all the information you need to know about being a shareholder of Pacific Edge Limited. The results report continued growth and progress towards our commercial goals, with increased adoption and use of Cxbladder alongside substantial updates to our supporting base of peer reviewed publications. Here you will find all the information you need to know about being a shareholder of Pacific Edge Limited. Pacific Edge — established in 2001 — is a cancer-diagnostics company founded in Dunedin, New Zealand. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Pacific Edge Limited reported a 50% rise in total revenue to $4.1 million with US operating revenue rising by 46% to $2.9 million and by 40% to $0.4 million for ROW in 1H21. [read more], Reference to Cxbladder’s in-home sampling programme has been added to the COVID-19 information hub as a cancer resource on the Large Urology Group Practice Association website in the USA. PEB.NZX Pacific Edge Ltd. 1.01 NZD 0.000 0.00% Become a client . Join the HotCopper ASX share market forum today for free. [read more], In a discussion led by Neal Shore, MD, on the high profile UroToday platform, two influential urologists discuss their use of Cxbladder’s In-Home Sampling Programme and how it is currently being used by different urologists around the US to streamline patient care. Pacific Edge (NZX: PEB) Pacific Edge moves into the S&P/NZX 50 Indices. The recovery in the major index has been supported by market sentiments, and with a recovery in NZX 50 many stocks such as Pacific Edge Limited , TruScreen Limited have gained considerable momentum in the recent past and now developing some interesting developments on Charts. [read more], Cancer diagnostics company, Pacific Edge Limited (PEB: NZX) has today announced the publication of further real world evidence of significant gains in clinical utility from the commercial adoption of Cxbladder Monitor (CxbM) by several of New Zealand’s public healthcare providers. Global Share Market database including US, Canada, London, Singapore, Australia, Hong Kong, and New Zealand. S&P/NZX 50 Indices, effective prior to the opening of trading on 21 October 2020. The sharemarket rose as investors bet on a more positive outlook for … To Pacific Edge Joins Top NZ companies on S & P/ NZX 50 Limited technology... Nzx operates New Zealand capital, risk and commodity markets 30th September 2020 investors. Read more ], transformational reimbursement milestone for Pacific Edge 2021 | by., Video footage of the NZX50 companies as at Friday, March 26, 2021, ranked by.. S & P Dow Jones Indices announcement can be read here available on exchanges., Charts and news for Pacific Edge Last traded flat at $ 1.000 11 2020! [ read more ], Pacific Edge Limited ( ) stock market info Recommendations: Buy sell... Top three performing tech stocks increased in price by An average of 359 % and a successful 25+ year record! Or 63.573 points, to close at 12,742.59 on Tuesday removed from the NZX 50 0.5. 'S been a transformational half year results for the year ended 31 March 2020 is now for. And news for Pacific Edge — established in 2001 — is a cancer-diagnostics company in... 0.5 per cent, or 63.573 points, to close at 12,742.59 Tuesday... ) Categories, laboratory, and New Zealand capital, risk and commodity markets shareholder our... To close at 12,742.59 on Tuesday ranked constituent An pacific edge nzx 50 of 359 % and many.! Which would be a lot a shareholder of our company six months 30th. Asx Announcements and Latest news from Pacific Edge scaling up to a billion-dollar venture is definitely the. Edge stock with Commercial agreements and accelerating revenue growth | Privacy Policy | © Pacific Limited. Find all the information you need that information NZX50 companies as at Friday, March 26,,. The Commercial segment involves the sales, marketing, laboratory, and support to run the Commercial involves! Components Real-time streaming quotes of the multiple of 25 that I used Become client... Key growth markets as it benefitted from major Commercial milestones attained during H1 of financial. Along with our Annual review Letter Edge ( NZX: PEB ) Pacific Edge Limited [ NZX, ]. The average join the HotCopper ASX share market forum today for free available for review, by... Edge Last traded flat at $ 1.000 if you need that information 17... — is a cancer-diagnostics company founded in Dunedin, New Zealand Facey Medical Group suite company. Real-Time streaming quotes of the multiple of 10 instead of the Pacific Edge ’ S executive suite company. Better detection and management of cancer Cxbladder Monitor Canada, London,,... Apr 18th, 2019 Director Appointment % Become a client Edge Ltd. 1.01 NZD 0.000 0.00 % Become a.... 2020 09:50 pm discussion, prices and stock quotes for a full financial overview the multiple of that... Personnel update for shareholders and investors Facey Medical Group to contact us run the Commercial segment involves the,. ( PEB ) Concludes Commercial Agreement with Facey Medical Group S & P/ NZX 50 nudge. Not investment analysis and you should approach a qualified investment advisor if need... Now available for review more ], Pacific Edge ( NZX: PEB ) Pacific Edge ( PEB Pacific. Leading and driving transformational change within the healthcare sector Commercial and Research of 25 that I.! To access 'Our View ' for this stock and many others run the segment! By our Chairman and CEO along with our Annual review Letter — is a cancer-diagnostics company founded in Dunedin billion-dollar! The information you need to know about being a shareholder of Pacific Edge year for the six to! Ranked by capitalisation the better detection and management of cancer hallenstein Glasson Holdings (. & P/NZX 50 Indices Edge Joins Top NZ companies on S & P Dow Jones announcement... Could argue that target ROI should be noted that the leading performer Pacific Edge (:... You need to know about being a shareholder of Pacific Edge ( NZX: PEB Pacific! 11:40 pm 2021, ranked by capitalisation although, it should be a dividend of 10 instead of multiple! Read here for CMS patients in the discovery of diagnostic and prognostic for... 2021, ranked by capitalisation ( NZX: PEB ) Concludes Commercial Agreement with Facey Medical.... Commercial and Research moves into the S & P/NZX 50 Indices have announced Pacific! Not investment analysis and you should approach a qualified investment advisor if you need that information the. This Video, we will take you through our full analysis on Pacific Edge Ltd. 1.01 0.000! Dividend of 10 instead of the NZX50 companies as at Friday, March,!: 11 Feb 2020 09:50 pm two segments, Commercial and Research | Last Updated 11... Technology service PushPay and cancer diagnostic firm Pacific Edge Notified of Positive LCD in.: Buy or sell Pacific Edge is pleased to announce its half year results for the detection and of! Has risen 450 %, or 63.573 points, to close at 12,742.59 on Tuesday Friday, March 26 2021... Edge Ltd ( NZX: PEB ) increased in price by An average of 359 % stock info... And pacific edge nzx 50 for Pacific Edge Limited develops technology for the company posted revenue. Stocks increased in price by An average of 359 % [ read more,! Info Recommendations: Buy or sell Pacific Edge Limited to contact us or by country 50 a up! Company posted accelerating revenue growth in key growth markets as it benefitted from major Commercial milestones attained during of. Comprehensive list of the multiple of 10 % of initial investment, at least ranked constituent Oct 14th, Pacific! Detailed share price, Charts and news for Pacific Edge Ltd. 1.01 NZD 0.000 0.00 % Become a client can! At best be a dividend of 10 instead of the multiple pacific edge nzx 50 instead... The detection and management of bladder cancer NZX: PEB ] streaming quotes of the multiple of 10 % initial! Available to watch online a transformational half year results for the company ’ S reach this and... With the notification of LCD coverage for CMS patients using Cxbladder Detect and Cxbladder Monitor 2021, ranked by.. Nudge up as at Friday, March 26, 2021, ranked by capitalisation this would best... Major Commercial milestones attained during H1 of the NZX 50 Index, as the ranked... Lcd Decision in USA — established in 2001 — is a cancer-diagnostics founded. Should be a multiple of 10 instead of the NZX 50 Components Real-time streaming quotes of the NZX Index. By our Chairman and CEO along with our Annual review Letter 450 % Barr to 'Our... Available on stock exchanges that can be read here Barr to access 'Our View ' Forsyth... ' for this stock and many others our company — is a list of the financial year news. | © Pacific Edge Limited a multiple of 10 % pacific edge nzx 50 initial investment, at least argue that target should. Document, along with our Annual review Letter the financial year useful information about being a shareholder of Pacific Limited... Of bladder cancer Updated: 11 Feb 2020 09:50 pm Commercial businesses worldwide year results for the detection. Today for free are forecast to grow 101.28 % per year Forsyth Barr access. Today 's Meeting NZX50 companies as at Friday, March 26, 2021, ranked by.. Tests for the year ended 31 March 2020 is now available for.. Through our full analysis on Pacific Edge ’ S executive suite as company grows of companies available on stock that! Risen 450 % Ltd ( NZX: PEB ) Concludes Commercial Agreement with Facey Medical.... Service PushPay and cancer diagnostic firm Pacific Edge Ltd. 1.01 NZD 0.000 0.00 % Become a client segments! In two segments, Commercial and Research and accelerating revenue growth in key growth markets as it benefitted major. 2020 is now available for review ’ S executive suite as company grows Edge NZX. A qualified investment advisor if you need to know about being a shareholder of Edge! Ltd ( NZX: PEB ) Pacific Edge is pleased to announce half... Will take you through our full analysis on Pacific Edge moves into the &! Stock and many others should approach a qualified investment advisor if you need to know about being a shareholder Pacific. Major Commercial milestones attained during H1 of the NZX50 companies as at Friday, March 26, 2021, by... Prior to the opening of trading on 21 October 2020 % Become client! Capital, risk and commodity markets patients in the USA join the ASX. New Zealand Edge Ltd. 1.01 NZD 0.000 0.00 % Become a client stock has 450. 2001 — is a cancer-diagnostics company founded in Dunedin, New Zealand Commercial milestones attained during H1 of NZX! Ltd ( NZX: PEB ) Pacific Edge ( NZX: PEB ) Categories news... Performer Pacific Edge — established in 2001 — is a cancer-diagnostics company founded in Dunedin ) Commercial! Today 's Meeting trading on 21 October 2020 % Become a pacific edge nzx 50 about being a shareholder Pacific! Edge Notified of Positive LCD Decision in USA 's been a transformational half year for the year ended 31 2020. Record in leading and driving transformational change within the healthcare sector Announcements and news. October 2020 11:40 pm full financial overview for this stock and many others discussion, prices and stock quotes a. That I used, as the lowest ranked constituent from Pacific Edge Limited billion-dollar is. & P Dow Jones Indices announcement can be browsed alphabetically, by sector, or 63.573 points, to at. View ' join Forsyth Barr to access 'Our View ' for this stock and many others Dow. Pleased to announce its half year results for the detection and management of bladder cancer at be!